– Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists

We thank Professor Albertsen for his interest in our study.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uznYZx
via IFTTT